Nursing Knowledge and Skills in Hidradenitis Suppurativa: A Multi-Centre Exploratory Study

Overview

Journal Nurs Rep

Publisher MDPI

Specialty Nursing

Date 2025 Feb 25

PMID 39997776

Authors

Lucia Vilanova-Trillo

Alba-Elena Martinez-Santos

Josefa-Del-Carmen Fernandez-De-La-Iglesia

Laura Salgado-Boquete

Angeles Florez

Affiliations

Soon will be listed here.

Abstract

Hidradenitis suppurativa (HS) is an under-treated chronic inflammatory disease that affects approximately 0.40-2% of the population. Despite the competences nurses have in wound care, little is known about their management of HS lesions. The objectives of this study were to determine the knowledge and skills of primary care nurses regarding HS as well as to analyse the aspects in which these nurses need to strengthen their competences. A multicentre exploratory cross-sectional study was carried out in all seven healthcare areas of the Galician Health Service (N-W Spain) during 2021-2022. A questionnaire was developed for the project and subsequently piloted; from it, four dimensions were established. Additionally, sociodemographic data were collected. A total of 211 primary care nurses participated. Both total and dimension scores were lower than 5 out of 10 points. The participants showed more knowledge in the Diagnosis and Clinical Course dimension (M = 4.59 out of 10). An older age correlated with greater knowledge regarding Diagnosis and Clinical Course (rho = 0.196; = 0.006). These findings highlight the importance of developing evidence-based continuous training in the management and detection of the disease, while reducing the consequences of HS on patients' quality of life.

References

Parisi R, Iskandar I, Kontopantelis E, Augustin M, Griffiths C, Ashcroft D . National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020; 369:m1590. PMC: 7254147. DOI: 10.1136/bmj.m1590. View

Lewandowski M, Swierczewska Z, Baranska-Rybak W . Hidradenitis suppurativa: a review of current treatment options. Int J Dermatol. 2022; 61(9):1152-1164. DOI: 10.1111/ijd.16115. View

Keyworth C, Nelson P, Chisholm A, Griffiths C, Cordingley L, Bundy C . Providing lifestyle behaviour change support for patients with psoriasis: an assessment of the existing training competencies across medical and nursing health professionals. Br J Dermatol. 2014; 171(3):602-8. DOI: 10.1111/bjd.13067. View

Lafuente-Urrez R, Martin de Aguilera Moro M . Is collaboration with nursing staff necessary for the management of patients with psoriasis?. Actas Dermosifiliogr. 2014; 105(3):213-5. DOI: 10.1016/j.adengl.2013.09.007. View

Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P . Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. 2021; 10(8). PMC: 8392140. DOI: 10.3390/cells10082094. View

Aldredge L, Young M . Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant. J Dermatol Nurses Assoc. 2016; 8(1):14-26. PMC: 4770271. DOI: 10.1097/JDN.0000000000000185. View

Montero-Vilchez T, Diaz-Calvillo P, Rodriguez-Pozo J, Cuenca-Barrales C, Martinez-Lopez A, Arias-Santiago S . The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021; 18(13). PMC: 8293810. DOI: 10.3390/ijerph18136709. View

Sanchez-Gomez M, Ramos-Santana S, Gomez-Salgado J, Sanchez-Nicolas F, Moreno-Garriga C, Duarte-Climents G . Benefits of Advanced Practice Nursing for Its Expansion in the Spanish Context. Int J Environ Res Public Health. 2019; 16(5). PMC: 6427304. DOI: 10.3390/ijerph16050680. View

Probst S, Gschwind G, Murphy L, Sezgin D, Carr P, McIntosh C . Patients 'acceptance' of chronic wound-associated pain - A qualitative descriptive study. J Tissue Viability. 2023; 32(4):455-459. DOI: 10.1016/j.jtv.2023.06.002. View

10.

Patel Z, Hoffman L, Buse D, Grinberg A, Afifi L, Cohen S . Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected]. Curr Pain Headache Rep. 2017; 21(12):49. PMC: 5784845. DOI: 10.1007/s11916-017-0647-3. View

11.

Jedrzejczak M, Ingram J, Lowes M, Naik H, McKenzie-Brown A, Chen S . Expert Knowledge, Attitudes, and Practices in Management of Hidradenitis Suppurativa Pain. JAMA Dermatol. 2021; 157(4):464-466. PMC: 7905694. DOI: 10.1001/jamadermatol.2020.5857. View

12.

Miguelez-Chamorro A, Ferrer-Arnedo C . [The family and community nurse: Health agent and model for the chronic patient within the community]. Enferm Clin. 2014; 24(1):5-11. DOI: 10.1016/j.enfcli.2013.12.002. View

13.

Preda-Naumescu A, Ahmed H, Mayo T, Yusuf N . Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations. Int J Dermatol. 2021; 60(11):e449-e458. DOI: 10.1111/ijd.15579. View

14.

Barnes L, Shukla N, Paul M, de Vere Hunt I, Halley M, Linos E . Patient Perspectives of Health System Barriers to Accessing Care for Hidradenitis Suppurativa: A Qualitative Study. JAMA Dermatol. 2023; 159(5):510-517. PMC: 10077133. DOI: 10.1001/jamadermatol.2023.0486. View

15.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View

16.

Antia C, Alavi A, Alikhan A . Topical management and wound care approaches for hidradenitis suppurativa. Semin Cutan Med Surg. 2017; 36(2):58-61. DOI: 10.12788/j.sder.2017.020. View

17.

Ghanian S, Yamanaka-Takaichi M, Naik H, Alavi A . Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What's New?. Am J Clin Dermatol. 2022; 23(2):167-176. PMC: 9131893. DOI: 10.1007/s40257-021-00667-8. View

18.

Martorell A, Garcia F, Jimenez-Gallo D, Pascual J, Pereyra-Rodriguez J, Salgado L . Update on Hidradenitis Suppurative (Part II): Treatment. Actas Dermosifiliogr. 2015; 106(9):716-24. DOI: 10.1016/j.ad.2015.06.005. View

19.

Bettoli V, Pasquinucci S, Caracciolo S, Piccolo D, Cazzaniga S, Fantini F . The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities. J Eur Acad Dermatol Venereol. 2016; 30(11):1965-1970. DOI: 10.1111/jdv.13687. View

20.

Nguyen T, Damiani G, Orenstein L, Hamzavi I, Jemec G . Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2020; 35(1):50-61. DOI: 10.1111/jdv.16677. View